These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24652348)

  • 1. Enterovirus 71 related severe hand, foot and mouth disease outbreaks in South-East Asia: current situation and ongoing challenges.
    Sabanathan S; Tan le V; Thwaites L; Wills B; Qui PT; Rogier van Doorn H
    J Epidemiol Community Health; 2014 Jun; 68(6):500-2. PubMed ID: 24652348
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular epidemiology of human enterovirus 71 at the origin of an epidemic of fatal hand, foot and mouth disease cases in Cambodia.
    Duong V; Mey C; Eloit M; Zhu H; Danet L; Huang Z; Zou G; Tarantola A; Cheval J; Perot P; Laurent D; Richner B; Ky S; Heng S; Touch S; Sovann L; van Doorn R; Tan Tran T; Farrar JJ; Wentworth DE; Das SR; Stockwell TB; Manuguerra JC; Delpeyroux F; Guan Y; Altmeyer R; Buchy P
    Emerg Microbes Infect; 2016 Sep; 5(9):e104. PubMed ID: 27651091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards broadly protective polyvalent vaccines against hand, foot and mouth disease.
    Liu Q; Tong X; Huang Z
    Microbes Infect; 2015 Feb; 17(2):155-62. PubMed ID: 25449959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enterovirus 71 causes hand, foot and mouth disease outbreak in Cambodia.
    Biswas T
    Natl Med J India; 2012; 25(5):316. PubMed ID: 23448647
    [No Abstract]   [Full Text] [Related]  

  • 5. Best practices to prevent transmission and control outbreaks of hand, foot, and mouth disease in childcare facilities: a systematic review.
    Chan JH; Law CK; Hamblion E; Fung H; Rudge J
    Hong Kong Med J; 2017 Apr; 23(2):177-90. PubMed ID: 28302925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines.
    Klein MH
    Expert Rev Vaccines; 2015 Mar; 14(3):337-40. PubMed ID: 25536888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protecting the most vulnerable from hand, foot, and mouth disease.
    Tan YW; Chu JJH
    Lancet Infect Dis; 2021 Mar; 21(3):308-309. PubMed ID: 33031751
    [No Abstract]   [Full Text] [Related]  

  • 8. EV71: an emerging infectious disease vaccine target in the Far East?
    Xu J; Qian Y; Wang S; Serrano JM; Li W; Huang Z; Lu S
    Vaccine; 2010 Apr; 28(20):3516-21. PubMed ID: 20304038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral outbreak in China tests government efforts.
    Qiu J
    Nature; 2009 Apr; 458(7238):554-5. PubMed ID: 19340040
    [No Abstract]   [Full Text] [Related]  

  • 10. Seroepidemiology of Coxsackievirus A10 infection in infants and children: A prospective cohort study in Jiangsu, China.
    Fu Y; Sun SY; Mao QY; Bian LL; Wu X; Zhu FC; Jiang CL; Gao F; Liang ZL
    J Infect; 2018 Aug; 77(2):158-164. PubMed ID: 29746947
    [No Abstract]   [Full Text] [Related]  

  • 11. Cambodian outbreak tests International Health Regulations.
    Lancet Infect Dis; 2012 Aug; 12(8):577. PubMed ID: 22795834
    [No Abstract]   [Full Text] [Related]  

  • 12. [Further improve the understanding of hand, foot and mouth disease].
    DU JB; Zhang QY
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2307-8. PubMed ID: 18036289
    [No Abstract]   [Full Text] [Related]  

  • 13. Is a multivalent hand, foot, and mouth disease vaccine feasible?
    Klein M; Chong P
    Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of the dynamics of enterovirus 71 infection by experimental-mathematical investigation.
    Fukuhara M; Iwami S; Sato K; Nishimura Y; Shimizu H; Aihara K; Koyanagi Y
    J Virol; 2013 Jan; 87(1):701-5. PubMed ID: 23097444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiologic and etiologic characteristics of hand, foot, and mouth disease in Chongqing, China between 2010 and 2013.
    Lai FF; Yan Q; Ge SX; Tang X; Chen RJ; Xu HM
    J Med Virol; 2016 Mar; 88(3):408-16. PubMed ID: 26255857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thinking about the intervention strategy for critically ill hand-foot-and-mouth disease caused by enterovirus 71 infection].
    Lu GP; Zhu QR
    Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):244-8. PubMed ID: 22801222
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of enterovirus 71 vaccines.
    Chong P; Liu CC; Chow YH; Chou AH; Klein M
    Clin Infect Dis; 2015 Mar; 60(5):797-803. PubMed ID: 25352588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine.
    Zhou Y; Li JX; Jin PF; Wang YX; Zhu FC
    Expert Rev Vaccines; 2016 Jul; 15(7):803-13. PubMed ID: 27206811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease.
    Lim H; In HJ; Lee JA; Sik Yoo J; Lee SW; Chung GT; Choi YK; Chung JK; Cho SJ; Lee JW
    Vaccine; 2018 Jun; 36(24):3445-3452. PubMed ID: 29739716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterovirus 71 Neutralizing Antibodies Seroepidemiological Research among Children in Guangzhou, China between 2014 and 2015: A Cross-Sectional Study.
    Zhang D; Chen Y; Chen X; He Z; Zhu X; Hao Y
    Int J Environ Res Public Health; 2017 Mar; 14(3):. PubMed ID: 28335535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.